Get the latest Science News and Discoveries
FDA-approved Alzheimer's drug lecanemab could prevent free-floating amyloid beta fibrils from damaging the brain
None
Or read this on ScienceDailyGet the latest Science News and Discoveries
None
Or read this on ScienceDailyRead more on:
Related news: